mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.009 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.009 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.009 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |